Radiotherapy of non-tumoral refractory ...
Type de document :
Compte-rendu et recension critique d'ouvrage
Titre :
Radiotherapy of non-tumoral refractory neurological pathologies
Auteur(s) :
Jacob, Julian [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Reyns, N. [Auteur]
Thérapies Assistées par Lasers et Immunothérapies pour l'Oncologie - U 1189 [OncoThAI]
Valéry, C.-A. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Feuvret, L. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Simon, J.-M. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Mazeron, J.-J. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Jenny, C. [Auteur]
STMicroelectronics [Crolles] [ST-CROLLES]
Cuttat, M. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Maingon, P. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Pasquier, David [Auteur]
Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] [UNICANCER/Lille]
CHU Pitié-Salpêtrière [AP-HP]
Reyns, N. [Auteur]
Thérapies Assistées par Lasers et Immunothérapies pour l'Oncologie - U 1189 [OncoThAI]
Valéry, C.-A. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Feuvret, L. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Simon, J.-M. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Mazeron, J.-J. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Jenny, C. [Auteur]
STMicroelectronics [Crolles] [ST-CROLLES]
Cuttat, M. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Maingon, P. [Auteur]
CHU Pitié-Salpêtrière [AP-HP]
Pasquier, David [Auteur]
Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] [UNICANCER/Lille]
Titre de la revue :
Cancer/Radiothérapie
Pagination :
523-533
Éditeur :
Elsevier Masson
Date de publication :
2020-10
ISSN :
1278-3218
Mot(s)-clé(s) en anglais :
radiotherapy
arteriovenous malformations
trigeminal neuralgia
tremor
arteriovenous malformations
trigeminal neuralgia
tremor
Discipline(s) HAL :
Sciences du Vivant [q-bio]/Cancer
Résumé en anglais : [en]
Intracranial radiotherapy has been improved, primarily because of the development of stereotactic approaches. While intracranial stereotactic body radiotherapy is mainly indicated for treatment of benign or malignant tumors, ...
Lire la suite >Intracranial radiotherapy has been improved, primarily because of the development of stereotactic approaches. While intracranial stereotactic body radiotherapy is mainly indicated for treatment of benign or malignant tumors, this procedure is also effective in the management of other neurological pathologies; it is delivered using GammaKnife ® and linear accelerators. Thus, brain arteriovenous malformations in patients who are likely to experience permanent neurological sequelae can be managed by single session intracranial stereotactic body radiotherapy, or radiosurgery, in specific situations, with an advantageous benefit/risk ratio. Radiosurgery can be recommended for patients with disabling symptoms, which are poorly controlled by medication, such as trigeminal neuralgia, and tremors, whether they are essential or secondary to Parkinson's disease. This literature review aims at defining the place of intracranial stereotactic body radiotherapy in the management of patients suffering from non-tumoral refractory neurological pathologies. It is clear that the multidisciplinary collaboration of experienced teams from Neurosurgery, Neurology, Neuroradiology, Radiation Oncology and Medical Physics is needed for the procedures using high precision radiotherapy techniques which deliver high doses to locations near functional brain areas.Lire moins >
Lire la suite >Intracranial radiotherapy has been improved, primarily because of the development of stereotactic approaches. While intracranial stereotactic body radiotherapy is mainly indicated for treatment of benign or malignant tumors, this procedure is also effective in the management of other neurological pathologies; it is delivered using GammaKnife ® and linear accelerators. Thus, brain arteriovenous malformations in patients who are likely to experience permanent neurological sequelae can be managed by single session intracranial stereotactic body radiotherapy, or radiosurgery, in specific situations, with an advantageous benefit/risk ratio. Radiosurgery can be recommended for patients with disabling symptoms, which are poorly controlled by medication, such as trigeminal neuralgia, and tremors, whether they are essential or secondary to Parkinson's disease. This literature review aims at defining the place of intracranial stereotactic body radiotherapy in the management of patients suffering from non-tumoral refractory neurological pathologies. It is clear that the multidisciplinary collaboration of experienced teams from Neurosurgery, Neurology, Neuroradiology, Radiation Oncology and Medical Physics is needed for the procedures using high precision radiotherapy techniques which deliver high doses to locations near functional brain areas.Lire moins >
Langue :
Anglais
Vulgarisation :
Non
Source :
Fichiers
- https://hal.sorbonne-universite.fr/hal-03114540/document
- Accès libre
- Accéder au document
- https://hal.sorbonne-universite.fr/hal-03114540/file/Jacob%20et%20al.%20-%202020%20-%20Radiotherapy%20of%20non-tumoral%20refractory%20neurologica.pdf
- Accès libre
- Accéder au document
- https://hal.sorbonne-universite.fr/hal-03114540/document
- Accès libre
- Accéder au document
- https://hal.sorbonne-universite.fr/hal-03114540/file/Jacob%20et%20al.%20-%202020%20-%20Radiotherapy%20of%20non-tumoral%20refractory%20neurologica.pdf
- Accès libre
- Accéder au document
- https://hal.sorbonne-universite.fr/hal-03114540/document
- Accès libre
- Accéder au document
- https://hal.sorbonne-universite.fr/hal-03114540/document
- Accès libre
- Accéder au document
- document
- Accès libre
- Accéder au document
- Jacob%20et%20al.%20-%202020%20-%20Radiotherapy%20of%20non-tumoral%20refractory%20neurologica.pdf
- Accès libre
- Accéder au document